Effect of Vacuum-Assisted Closure Therapy on the expression of cytokines and proteases in wound fluid of adults with pressure ulcers

Wound Repair and Regeneration

Volumn 14, Issue 3, 2006, Pages 371-373

  Stechmiller, Joyce K ^a   Kilpadi, Deepak V ^b   Childress, Beverly ^a   Schultz, Gregory S ^c  

^a UNIVERSITY OF FLORIDA   (United States)

^b Kinetic Concepts Inc   (United States)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GELATINASE A; INTERLEUKIN 1; INTERLEUKIN 1BETA; MATRIX METALLOPROTEINASE; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANALYSIS OF VARIANCE; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CYTOKINE PRODUCTION; DECUBITUS; ENZYME ANALYSIS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATORY CELL; LETTER; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; VACUUM ASSISTED CLOSURE; WOUND HEALING;

EID: 33745519158     PISSN: 10671927     EISSN: 1524475X     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2006.00134.x     Document Type: Letter

References (31)

1. U.S. Department of Health and Human Services Public Health Service Agency for Health Care Policy and Research. Pressure Ulcer Treatment. AHCPR Publication No. 95-0653. Rockville, MD: U.S. Department of Health and Human Services Public Health Service Agency for Health Care Policy and Research.
2. Wysocki A, Staiano L, Grinnell F. Wound fluid from chronic leg ulcers contains elevated levels of metalloproteinases MMP-2 and MMP-9. J Invest Dermatol 1993; 101: 64.
3. Schultz G. Molecular regulation of the wound environment. In: Bryant RA, editor. Acute and chronic wounds. 2nd ed. St. Louis: Mosby, 1994.
4. Joseph E, Hamori CA, Bergman S, Roaf E, Swann NF, Anastasi GW. New therapeutic approaches in wound care. A prospective randomized trial of vacuum-assisted closure versus standard therapy of chronic nonhealing wounds. Wounds - A Compend Clin Res Pract 2000; 12: 60-7.
5. McCallon SK, Knight CA, Valiulus JP, Cunningham MW, McCulloch JM, Farinas LP. Vacuum-assisted closure versus saline-moistened gauze in the healing of postoperative diabetic foot wounds. Ostomy Wound Management 2000; 46: 28-32.
6. Morykwas MJ, Argenta LC, Shelton-Brown EI, McGuirt W. Vacuum-assisted closure: a new method for wound control and treatment: animal studies and basic foundation. Ann Plast Surg 1997; 38: 553-62.
7. Philbeck TE Jr., Whittington KT, Millsap MH, Briones RB, Wight DG, Schroeder WJ. The clinical and cost-effectiveness of externally applied negative pressure wound therapy in the treatment of wounds in home healthcare Medicare patients. Ostomy, Wound Manage 1999; 45: 41-50.
8. Portney LG, Watkins MP. Foundations of clinical research - Applications to practice. 2nd ed. Upper Saddle River, NJ: Prentice-Hall, 2000.
9. Trengove NJ, Stacey MC. Endotoxin and nitric oxide metabolites in wound fluid from non-healing and healing chronic leg ulcers. Wound Rep Reg 1995; 3: 397.
10. Kilpadi DV, Childress B, Blalock T, et al. The effect of V.A.C.® Granufoam™ dressing and tubing on MMP-2, MMP-3, TNF-α, IL-1β, TIMP-1, and TIMP-2 concentrations in pressure ulcer wound fluid. 2nd Congress of the World Union of Wound Healing Societies, Paris, France, July 2004.
11. Kilpadi DV, Kail S, Kalns J, et al. Wound fluid collection for V.A.C.® Therapy based studies. 2nd Congress of the World Union of Wound Healing Societies, Paris, France, July 2004.
12. Mast BA, Schultz GS. Interactions of cytokines, growth factors, and proteases in acute and chronic wounds. Wound Rep Reg 1996; 4: 411-20.
13. Bryant RA. Acute and chronic wounds: Nursing management. 2nd ed. St. Louis, MO: Mosby Inc, 2000.
14. Yager DR, Chen SM, Ward S, Olutoye OO, Diegelmann RF, Cohen IK. The ability of chronic wound fluids to degrade peptide growth factors is associated with increased levels of elastase activity and diminished levels of proteinase inhibitors. Wound Rep Reg 1997; 5: 23-32.
15. Tarnuzzer RW, Schultz GS. Biochemical analysis of acute and chronic wound environments. Wound Rep Reg 1996; 4: 321-5.
16. Fitzgerald KA, O'Nei LAJ, Gearin AJH, Callard RE, editors The cytokine factsbook. 2nd Ed. San Diego, CA: Academic Press, 2001.
17. Bower CE, Kilpadi DV, Reade CC, et al. Effect of negative pressure wound therapy on systemic cytokine levels in swine. 2nd Congress of the World Union of Wound Healing Societies, Paris, France, July 2004.
18. Han YP, Tuan TL, Wu H, Hughes M, Garner WL. TNF-alpha stimulates activation of pro-MMP-2 in human skin through NF-(kappa) B mediated induction of MT1-MMP. J Cell Sci 2001; 114: 131-9.
19. Catrina AI, Lampa J, Ernestam S, af Klint E, Bratt J, Klareskog L, Ulfgren AK. Anti-tumour necrosis factor (TNF)-alpha therapy (etanercept) down-regulates serum matrix metalloproteinase (MMP)-3 and MMP-1 in rheumatoid arthritis. Rheumatology (Oxford) 2002 May; 41: 484-9.
20. Kusano K, Miyaura C, Inada M, Tamura T, Ito A, Nagase H, Kamoi K, Suda T. Regulation of matrix metalloproteinases (MMP-2, -3, -9, and -13) by interleukin-1 and interleukin-6 in mouse calvaria: association of MMP induction with bone resorption. Endocrinology 1998; 139: 1338-45.
21. Ladwig GP, Robson MC, Liu R, Kuhn MA, Muir DF, Schultz GS. Ratios of activated matrix metalloproteinase-9 to tissue inhibitor of matrix metalloproteinase-1 in wound fluids are inversely correlated with healing of pressure ulcers. Wound Rep Reg 2002; 10: 26-37.
22. Bullard KM, Lund L, Mudgett JS, Mellin TN, Hunt TK, Murphy B, Ronan J, Werb Z, Banda MJ. Impaired wound contraction in stromelysin-1-deficient mice. Ann Surg 1999; 230: 260-5.
23. Shi B, Chen S, Zhang P, Li J. Effects of vacuum-assisted closure on the expression of MMP-1, MMP-2 and MMP-13 mRNA in human granulation wounds (Chinese). Zhonghua Zheng Xing Wai Ke Za Zhi 2003; 19: 279-81.
24. Burchett SK, Weaver WM, Westall JA, Larsen A, Kronheim S, Wilson CB. Regulation of tumor necrosis factor/cachectin and IL-1 secretion in human mononuclear phagocytes. J Immunol 1988; 140: 3473-81.
25. Dasu MR, Barrow RE, Spies M, Herndon DN. Matrix metalloproteinase expression in cytokine stimulated human dermal fibroblasts. Burns 2003; 29: 527-31.
26. Wright JK, Cawston TE, Hazleman BL. Transforming growth factor beta stimulates the production of the tissue inhibitor of metalloproteinases (TIMP) by human synovial and skin fibroblasts. Biochim Biophys Acta 1991; 1094: 207-10.
27. Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases. Structure, function, and biochemistry. Circ Res 2003; 92: 827-39.
28. Vaalamo M, Weckroth M, Puolakkainen P, Kere J, Saarinen P, Lauharanta J, Saarialho-Kere UK. Patterns of matrix metalloproteinase and TIMP-1 expression in chronic and normally healing human cutaneous wounds. Br J Dermatol 1996; 135: 52-9.
29. Vaalamo M, Leivo T, Saarialho-Kere U. Differential expression of tissue inhibitors of metalloproteinases (TIMP-1, -2, -3, and -4) in normal and aberrant wound healing. Human Pathol 1999; 30: 795-802.
30. Hornebeck W. Down-regulation of tissue inhibitor of matrix metalloprotease-1 (TIMP-1) in aged human skin contributes to matrix degradation and impaired cell growth and survival. Pathol Biol 2003; 51: 569-73.
31. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Eng J Med 1999; 340: 448-54.